13 August 2007
Journal of Commercial Biotechnology
I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to make a submission.
The most recent issue, edited by Neil Henderson, has just been published:
Volume 13, Issue 3
- When should you fire the founder?
- Constructing a processual model of communication in new product development from a multiple case study of biotechnology SMEs
- A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape
- Measuring performance of field-medical programmes: Medical science liaison metrics consensus
- The commercialisation of bioinformatics and the threat of open-source software
- Intellectual property issues in nanotechnology
- Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost?
- Changing hopes and concerns about gene therapy in Japan
- Legal and Regulatory Update
William Bains
Jennifer Frahm, David C Ireland and Damian Hine
Gareth Williams
Jane Chin
Joseph F Greco
Lars Genieser and Michael Gollin
Pedro Reinares Lara and Emma Gutierrez de Mesa
Darryl Macer, Yoshihiro Okada, Makoto Nakagawa, MaryAnn Chen Ng and Masakazu Inaba
ReedSmith
The Journal of Commercial Biotechnology is online at http://www.palgrave-journals.com/jcb. If purchasing a subscription, please use subscriber code NH0707G01.
2 Comments currently posted.
James says:
Rate of Attrition » Blog Archive » Running on Empty… for This says:
[...] 2500+ word plus manuscript for journal publication (one of my manuscripts was just published in the Journal of Commercial Biotechnology). I wrote two poems recently (I shared one of them publicly here) - and I rarely write poetry. I [...]








Friedman,
Well, congratulations and all the best. You’re a hardworking man…there’s no doubt about that.